Trial Profile
EFFECTS OF ATORVASTATIN ON BLOOD PRESSURE AND URINARY ALBUMIN EXCRETION IN PATIENTS WITH ESSENTIAL HYPERTENSION.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Essential hypertension; Hypercholesterolaemia
- Focus Pharmacodynamics
- Acronyms STAY
- 01 Sep 2011 Results published in the Journal of Human Hypertension.
- 20 Jun 2011 Results assessing the effect of treatment on ambulatory blood pressure presented at the 21st European Meeting on Hypertension.
- 20 Jun 2011 Pharmacodynamic analysis results presented at the 21st European Meeting on Hypertension.